Leaked IPR Draft Revives India’s Data Protection Bogey?
This article was originally published in PharmAsia News
Executive Summary
A leaked final draft of India's national intellectual property rights (IPR) policy suggests creating an "appropriate framework" for protection of undisclosed information submitted in the drug approval process, though it does not endorse data exclusivity.